Cover Image
市場調查報告書

生物醫藥品用生物分離系統的全球市場

Biopharmaceutical Bioseparation Systems

出版商 Global Industry Analysts, Inc. 商品編碼 352665
出版日期 內容資訊 英文 258 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物醫藥品用生物分離系統的全球市場 Biopharmaceutical Bioseparation Systems
出版日期: 2016年02月01日 內容資訊: 英文 258 Pages
簡介

本報告提供全球生物醫藥品用生物分離系統市場相關調查,彙整從2014年到2020年的市場成長預測,各地區趨勢,以及進入此市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 今後預測
    • 生物分離系統:生物醫藥品製造上的價值工具
    • 即使美國持續領導市場,仍是發展中國家推動市場成長
    • 層析法領導市場
    • 競爭環境
  • 產業檢討
  • 生物分離技術:主要趨勢
  • 產品概要
    • 生物製品:概要
    • 各用途分類
    • 化學性質別分類
    • 生物分離:概要
    • 一般所採用的生物分離流程
    • 生物分離:問題多,複雜且高價的流程
    • 與生分子回收階段相關的生物分離技術
    • 基於分辨率與處理量之生物分離技術的分類
    • 生物製品的處理比例之生物分離成本 其他
  • 近幾年的產業活動
  • 主要企業
    • 3M Company
    • 3M Purification, Inc.
    • Agilent Technologies, Inc.
    • Alfa Wassermann Separation Technologies, LLC
    • Flottweg Separation Technology
    • GEA Westfalia Separator Group GmbH
    • GE Healthcare
    • KNAUER Wissenschaftliche Gerate GmbH
    • Konik Nanobiotech SL
    • Merck KGaA
    • NuSep Holdings Ltd.
    • Pall Corporation
    • ProMetic Life Sciences, Inc.
    • Sartorius Stedim Biotech
    • Spectrum Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Tosoh
    • YMC Europe GmbH
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

第4章 競爭環境

目錄
Product Code: MCP-7973

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 52 companies including many key and niche players such as -

3M Company
Agilent Technologies, Inc.
Alfa Wassermann Separation Technologies, LLC
Flottweg Separation Technology
GEA Westfalia Separator Group GmbH

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
  • US Remains Market Leader; Developing Countries to Drive Market Growth
  • Chromatography Leads the Pack
  • Competitive Landscape
    • Table 1: Leading Players in the Global Biopharmaceutical Bioseparation Systems Market (2014): Percentage Breakdown of Revenues for 3M Purification, GE Healthcare Life Sciences, Merck Millipore, Pall Corporation, Sartorius and Others (includes corresponding Graph/Chart)

2. INDUSTRY OVERVIEW

  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products - An Overview
  • Growing Biopharmaceuticals Market Drives Demand for Bioseparation Systems
  • 2014-15: A Launch-Driven Period for Biopharmaceuticals
    • Recently Approved Biopharmaceuticals: 2013, 2014 & 2015
  • Biopharmaceutical Industry Transforms Downstream Processing
  • Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects
  • Approved Monoclonal Antibodies for Therapeutic Use: 1986-2014
  • An Insight into Bioseparation of mAbs
  • Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
    • Table 2: Global Biosimilars Market Size Estimates and Forecasts: 2012-2018F (includes corresponding Graph/Chart)
  • 2015: A year of Patent Expiries for Biologics
    • Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
  • R&D Funding Crucial for Biologics and Bioseparation market
    • Table 3: Global Biopharmaceutical R&D Expenditure: 2010- 2015E (includes corresponding Graph/Chart)
  • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
    • Table 4: Biopharmaceutical Products' Pipeline by Therapeutic Category (2015) (includes corresponding Graph/Chart)
    • Table 5: No. of Pipeline Biopharmaceuticals for Cancer by Site (2015) (includes corresponding Graph/Chart)
    • Table 6: No. of Pipeline Biopharmaceuticals for HIV/AIDS Treatment by Type of Therapy (2015) (includes corresponding Graph/Chart)
  • Insulin Products in Development
  • Growing Biological Drug Manufacturing Capacity to Drive Growth

3. BIOSEPARATION TECHNOLOGIES - KEY TRENDS

  • Increasing Need for Further Advances in Downstream Processing Techniques
  • Process Optimization and Cost Reduction - Key Goals of Innovations in Bioseparation
  • Single-Use Disposable Technologies Gain Attention
  • Select Commercial Disposable/Single-Use Technologies by Process Technique
  • Innovations in Single-use Systems
  • Changing Paradigm of Primary Recovery in Bioseparation
  • Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
  • Chromatography - the Gold Standard Purification Technology
  • Bioprocess Membrane Technology Offers Significant Benefits over Conventional Technologies
  • Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
    • A Comparison of Protein and Synthetic Ligands
  • Increasing Alternatives to Protein A Column based Capturing
    • Twin-Column SMB - An Emerging Alternative to Protein A Columns
  • Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
  • SMBC - An Old Approach Gaining Significant Attention
    • A Comparison of Major Advantages and Disadvantages of SMBC
  • Magnetic Separation as an Alternative to Chromatography - A Review
  • Reversible Precipitation - A Novel Bioseparation Technology

4. PRODUCT OVERVIEW

  • Biological Products - An Overview
  • Classification of Biological Products by Application
  • Classification of Biological Products by Chemical Nature
  • Bioseparation - An Overview
  • Commonly Used Bioseparation Processes by Factors
  • Bioseparation - A Challenging, Complex and Expensive Process
  • Stages of Biomolecule Recovery and Relevant Bioseparation Techniques Used
  • Classification of Bioseparation Techniques based on Resolution and Throughput
  • Bioseparation Costs as a Percentage of Processing by Biological Product
  • Key Bioseparation Techniques
  • Chromatography
  • Centrifugation
  • Membrane Separation
  • Filtration
  • Overview of Other Bioseparation Techniques
    • Adsorption
    • Extraction
    • Precipitation
  • Classification of Bioseparation Techniques based on Physical Form
  • Particle-Liquid Separation
  • Particle-Particle Separation
  • Solute-Solvent Separation
  • Solute-Solute Separation
  • Liquid-Liquid Separation
  • Particle-Solute Separation
  • RIPP in Bioseparation - The Conventional Scheme for Developing Processes

5. RECENT INDUSTRY ACTIVITY

  • Merck Acquires Sigma-Aldrich
  • EMD Millipore Launches Sterilizing-Grade Millipore Express(r) PHF Hydrophilic Filters
  • Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
  • GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind(tm) Technology
  • EMD Millipore Unveils Pellicon(r) Tangential Flow Filtration System
  • ImmunoReagents and ProteoVec Launch PV-Pure Ig(tm) Antibody Purification Kits
  • Pall Acquires Tarpon's BioSMB Platform
  • AMSBIO Introduces MagSi-Direct for Bioseparations
  • EMD Millipore Rolls Out PureFlex(tm) Plus Disposable Process Container Film
  • EMD Millipore Rolls Out New Resins for Chromabolt(r) Chromatography Columns
  • Thermo Fisher Scientific Launches New Chromatography Resin
  • Thermo Fisher Scientific to Introduce GlycanPac AXR-1 Column at Pittcon 2014
  • Pall Corporation Acquires ATMI's Life Sciences Business Division
  • Purolite to Develop Bioseparation Resins for Chromatography
  • EMD Millipore Unveils Innovative Single-Stage Clarification Clarisolve(r) Depth Filters
  • Thermo Fisher Scientific Introduces New 3000 BioRS System
  • Thermo Fisher Scientific Launches SEC-300 and SEC-1000 HPLC Columns
  • EMD Millipore Introduces Smart Flexware(r) Assemblies Along with Mobius(r) FlexReady Solution

6. FOCUS ON SELECT PLAYERS

  • 3M Company (US)
  • 3M Purification, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Alfa Wassermann Separation Technologies, LLC (US)
  • Flottweg Separation Technology (US)
  • GEA Westfalia Separator Group GmbH (Germany)
  • GE Healthcare (UK)
  • KNAUER Wissenschaftliche Gerate GmbH (Germany)
  • Konik Nanobiotech SL (Spain)
  • Merck KGaA (Germany)
  • NuSep Holdings Ltd. (Australia)
  • Pall Corporation (US)
  • ProMetic Life Sciences, Inc. (Canada)
  • Sartorius Stedim Biotech (France)
  • Spectrum Laboratories, Inc. (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Tosoh Bioscience, Inc. (Japan)
  • YMC Europe GmbH (Germany)

7. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 9: World 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 10: World Recent Past, Current & Future Analysis for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 12: World 11-Year Perspective for Chromatography Systems for Biopharmaceutical Bioseparation by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for Other Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Other Biopharmaceutical Bioseparation Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 15: World 11-Year Perspective for Other Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa and Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • United States: The Largest Biopharmaceutical Market Globally
    • Table 16: No. of Biologics Approved by the Center for Biologics Evaluation and Research (CBER): 2003-2013 (includes corresponding Graph/Chart)
    • Impending Patent Expiries Signal Growth Prospects
    • Table 17: Leading US Biopharmaceuticals by Revenue (in US$ Billion) and Year of Patent Expiry (includes corresponding Graph/Chart)
    • Select Trends in Biopharmaceutical Market
      • Manufacturers Shift Focus to Small Bioreactors
      • Biosimilar Drug Developers Face Higher Litigation Risks
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 18: US Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: US Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 20: US 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Canada - A Lucrative Biopharmaceutical Industry
    • Key Player
  • B. Market Analytics
    • Table 21: Canadian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: Canadian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 23: Canadian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Key Player
  • B. Market Analytics
    • Table 24: Japanese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 25: Japanese Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 26: Japanese 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Select Trends in the European Biopharmaceutical Industry
      • Funding Challenges Faced by Biopharmaceutical Startups
      • Healthcare Agencies Looking to Embrace Biosimilars to Cut Healthcare Costs
  • B. Market Analytics
    • Table 27: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: European Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of European Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 29: European 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of European Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 30: European Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 31: European Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 32: European 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Key Player
  • B. Market Analytics
    • Table 33: French Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: French Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 35: French 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 36: German Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: German Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 38: German 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 39: Italian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: Italian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 41: Italian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 42: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 43: UK Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 44: UK 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
    • Key Player
  • B. Market Analytics
    • Table 45: Spanish Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 46: Spanish Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 47: Spanish 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current & Future Analysis
    • Russia Sets Eyes on Emerging as a Notable Pharmaceutical Industry
    • Encouragement for Local Manufacturing to Drive Demand
    • Challenges - Need for Extensive R&D
  • B. Market Analytics
    • Table 48: Russian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 49: Russian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 50: Russian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • Market Analysis
    • Table 51: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 52: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 53: Rest of Europe 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Regional Biopharma Players Gain Strength by Innovation and Partnerships
    • Asia Set to Emerge as Preferred Outsourcing Destination for Biopharma Manufacturing
      • Availability of Scientific Talent - Major Advantage for India
  • B. Market Analytics
    • Table 54: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 55: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 56: Asia-Pacific 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 57: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 58: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 59: Asia-Pacific 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • Market Analysis
    • Table 60: Chinese Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 61: Chinese Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 62: Chinese 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • Market Analysis
    • Table 63: Indian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Indian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 65: Indian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 66: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 67: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 68: Rest of Asia-Pacific 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

  • Market Analysis
    • Table 69: Middle East & African Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 70: Middle East & African Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 71: Middle East & African 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • Market Analysis
    • Table 72: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 73: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 74: Latin American 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin American Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 75: Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 76: Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 77: Latin American 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

7a. BRAZIL

  • Market Analysis
    • Table 78: Brazilian Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 79: Brazilian Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 80: Brazilian 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

7b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 81: Rest of Latin American Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 82: Rest of Latin American Historic Review for Biopharmaceutical Bioseparation Systems by Segment - Chromatography Systems and Other Systems Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2010 through 2013 (includes corresponding Graph/Chart)
    • Table 83: Rest of Latin American 11-Year Perspective for Biopharmaceutical Bioseparation Systems by Segment - Percentage Breakdown of Revenues for Chromatography Systems and Other Systems Markets for Years 2010, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top